These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17415002)

  • 21. Magnetic resonance imaging in multiple sclerosis.
    Napoli SQ; Bakshi R
    Rev Neurol Dis; 2005; 2(3):109-16. PubMed ID: 16400309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
    Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.
    Matthews PM; De Stefano N; Narayanan S; Francis GS; Wolinsky JS; Antel JP; Arnold DL
    Semin Neurol; 1998; 18(3):327-36. PubMed ID: 9817537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D; Miller D
    J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on multiple sclerosis.
    Simon JH
    Radiol Clin North Am; 2006 Jan; 44(1):79-100, viii. PubMed ID: 16297683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis.
    Blumenthal S
    Radiol Technol; 2006; 77(4):309-21, quiz 322-5. PubMed ID: 16543484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
    Bendszus M; Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Stoll G
    Brain; 2008 Sep; 131(Pt 9):2341-52. PubMed ID: 18669504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conventional MRI in multiple sclerosis.
    Filippi M; Rocca MA
    J Neuroimaging; 2007 Apr; 17 Suppl 1():3S-9S. PubMed ID: 17425727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of MRS and fMRI in multiple sclerosis.
    Tartaglia MC; Arnold DL
    Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
    Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
    Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging spinal cord damage in multiple sclerosis.
    Rocca MA; Hickman SJ; Bö L; Agosta F; Miller DH; Comi G; Filippi M
    J Neuroimaging; 2005 Oct; 15(4):297-304. PubMed ID: 16254392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.
    Filippi M; Falini A; Arnold DL; Fazekas F; Gonen O; Simon JH; Dousset V; Savoiardo M; Wolinsky JS;
    J Magn Reson Imaging; 2005 Jun; 21(6):669-75. PubMed ID: 15906322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadofluorine M-enhanced magnetic resonance nerve imaging: comparison between acute inflammatory and chronic degenerative demyelination in rats.
    Wessig C; Jestaedt L; Sereda MW; Bendszus M; Stoll G
    Exp Neurol; 2008 Mar; 210(1):137-43. PubMed ID: 18061168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
    Al-Saeed O; Ismail M; Athyal R; Sheikh M
    Acta Radiol; 2011 Jun; 52(5):570-4. PubMed ID: 21498296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in imaging of multiple sclerosis.
    Poloni G; Minagar A; Haacke EM; Zivadinov R
    Neurologist; 2011 Jul; 17(4):185-204. PubMed ID: 21712664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.